Who owns the ANANDAMIDEPRO trademark?

The ANANDAMIDEPRO trademark is owned by Tesseract Medical Research, LLC.

What class is the ANANDAMIDEPRO trademark registered in?

The ANANDAMIDEPRO trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for ANANDAMIDEPRO?

The USPTO serial number for ANANDAMIDEPRO is 98894871.

What is the registration number for ANANDAMIDEPRO?

ANANDAMIDEPRO is registered under USPTO registration number 8226023.

ANA

USPTO Trademark Record

REGISTERED

ANANDAMIDEPRO

SN 98894871·Reg 8226023·Filed Dec 10, 2024

Owner Tesseract Medical Research, LLC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ANANDAMIDEPRO (Serial No. 98894871), Registration No. 8226023, is a registered US trademark filed on Dec 10, 2024 by Tesseract Medical Research, LLC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: April 21, 2032

Mark Intelligence

ANANDAMIDEPRO (Reg. #8226023) is a registered US trademark that has been protecting its owner, Tesseract Medical Research, LLC, since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 10, 2024

SERIAL

98894871

REG#

8226023

REGISTERED

Apr 21, 2026

Owner

Applicant

Tesseract Medical Research, LLC

Entity

LLC

State

Address

25095 Mustang Drive, Laguna Hills, CA, 92653

Country

Attorney

Law firm

Tesseract Medical Research, LLC

Address

25095 Mustang Drive, Laguna Hills, CA 92653, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateDec 10, 2024

Serial Number98894871

Registration No.8226023

Registration DateApr 21, 2026

Status DateApr 21, 2026

Published for OppositionApr 08, 2025

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Apr 07, 2025

First use in commerce: Apr 07, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

22 events

REGISTERED-PRINCIPAL REGISTER

Apr 21, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 21, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 30, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 30, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 19, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Mar 19, 2026

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Sep 12, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Sep 12, 2025

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 03, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 08, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 08, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 02, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 12, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 06, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 06, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 06, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Feb 25, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 25, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 25, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Feb 18, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Dec 10, 2024

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 10, 2024

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

ANANDAMIDEPRO

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Tesseract Medical Research, LLC

Resources

Company